Trial Profile
Phase I study of ISIS-DMPKRx in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Baliforsen (Primary)
- Indications Myotonic dystrophy
- Focus Adverse reactions
- 04 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology